SCHEMBL8166192

SCHEMBL8166192

O=C(O)CCC1CNCCC1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 1/20 0.40
KDM4E B2RXH2 2/20 0.36
SLC6A1 P30531 2/20 0.35
GABRA5 P31644 2/20 0.35
GABRB2 P47870 2/20 0.35
SLC6A12 P48065 2/20 0.35
SLC6A11 P48066 2/20 0.35
SLC6A13 Q9NSD5 2/20 0.35
GABRA1 P14867 1/20 0.35
GABRR1 P24046 1/20 0.35
GABRA4 P48169 1/20 0.35
NPC1 O15118 3/20 0.32
RAB9A P51151 3/20 0.32
SMN1; SMN2 Q16637 2/20 0.32
LMNA P02545 1/20 0.32
KMT2A Q03164 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GAA P10253 1/20 0.31
ALDH1A1 P00352 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27970459 0.98 FOLH1 (0.39) FOLH1KDM4ESLC6A1GABRA5GABRB2
SCHEMBL1478256 0.81 SLC6A1 (0.46) KDM4ESLC6A1GABRA5GABRB2SLC6A12
Hydrochloric Acid SCHEMBL28790221 0.80 SLC6A12 (0.44) KDM4ESLC6A1GABRA5GABRB2SLC6A12
SCHEMBL27741990 0.75
SCHEMBL15355111 0.74 NPSR1 (0.40) FOLH1KDM4ESMN1; SMN2LMNAKMT2A
SCHEMBL3557491 0.73 HSD17B10 (0.35) KDM4EKMT2AALDH1A1HPGD
SCHEMBL6978155 0.72
SCHEMBL3625534 0.72 KDM4E (0.57) FOLH1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL6756413 0.71 GBA1 (0.39)
SCHEMBL28333223 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6075038-A Alpha 1a adrenergic receptor antagonists MERCK & CO., INC. (US) 2000-06-13 US disclosed
US-5922722-A PIPERIDINE OR PIPERAZINE DERIVATIVES TO TREAT BENIGN PROSTATIC HYPERPLASIA MERCK & CO., INC. (US) 1999-07-13 US disclosed
EP-0831823-A4 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO INC (US) 1998-10-21 EP disclosed
EP-0865280-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-09-23 EP disclosed
EP-0831823-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS Merck & Co., Inc. (US) 1998-04-01 EP disclosed
WO-1997017967-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1997-05-22 WO disclosed
US-5620993-A Alpha-1a adrenergic receptor antagonists MERCK & CO., INC. (US) 1997-04-15 US disclosed
WO-1996040135-A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS MERCK & CO., INC. (US) 1996-12-19 WO disclosed